Harada, N <br/><br/>
Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients.  [electronic resource] 

 -  Diabetes research and clinical practice  Feb 1999 
 - 111-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0168-8227 
<br/><br/><label>Standard No.: </label>10.1016/s0168-8227(98)00124-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticholesteremic Agents--therapeutic use<br/>Apolipoproteins B--blood<br/>Blood Glucose--metabolism<br/>Body Mass Index<br/>Cholesterol--blood<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Female<br/>Humans<br/>Hypercholesterolemia--blood<br/>Lipid Peroxidation<br/>Lipid Peroxides--blood<br/>Lipoproteins--blood<br/>Lipoproteins, IDL<br/>Lipoproteins, LDL--blood<br/>Male<br/>Middle Aged<br/>Phospholipids--blood<br/>Pravastatin--therapeutic use<br/>Probucol--therapeutic use<br/>Regression Analysis<br/>Smoking<br/>Time Factors<br/>Triglycerides--blood